Paul Emery Selected Research

Paul Emery Research Topics

Disease

263	Rheumatoid Arthritis 06/2022 - 02/2002
41	Synovitis 01/2022 - 03/2002
39	Necrosis 11/2020 - 01/2004
38	Arthritis (Polyarthritis) 01/2022 - 08/2002
37	Inflammation (Inflammations) 01/2022 - 02/2002
21	Infections 10/2020 - 06/2004
20	Pain (Aches) 01/2022 - 03/2007
20	Rheumatic Diseases (Rheumatism) 01/2019 - 12/2003
19	Ankylosing Spondylitis 11/2021 - 01/2003
17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2022 - 10/2003
17	Psoriatic Arthritis 01/2022 - 02/2003
15	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2004
12	Fatigue 09/2019 - 09/2006
7	Edema (Dropsy) 01/2022 - 02/2002
7	Osteitis 01/2021 - 11/2011
6	Arthralgia (Joint Pain) 01/2022 - 10/2006
6	Fibrosis (Cirrhosis) 12/2021 - 11/2013
6	Neoplasms (Cancer) 03/2020 - 01/2005
6	Chronic Disease (Chronic Diseases) 09/2019 - 02/2002
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 06/2007
6	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 11/2002
6	Disease Progression 01/2018 - 01/2003
6	Osteoarthritis 07/2013 - 08/2002
5	Skin Diseases (Skin Disease) 01/2020 - 05/2008
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2013 - 05/2009
4	Body Weight (Weight, Body) 12/2015 - 11/2003
3	Tenosynovitis 11/2021 - 10/2007
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 08/2013
3	Neutropenia 11/2019 - 12/2015
3	Periodontal Diseases (Periodontal Disease) 01/2019 - 09/2015
3	Hypertension (High Blood Pressure) 01/2018 - 03/2007
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2017 - 11/2002
3	Joint Diseases (Joint Disease) 02/2014 - 01/2008
2	Axial Spondyloarthritis 07/2022 - 09/2013

Drug/Important Bio-Agent (IBA)

81	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2002
50	Antirheumatic Agents (DMARD)IBA 07/2022 - 11/2003
49	Rituximab (Mabthera)FDA Link 01/2021 - 06/2004
44	Biological ProductsIBA 07/2022 - 08/2005
32	Etanercept (Enbrel)FDA Link 01/2021 - 01/2004
31	Abatacept (Orencia)FDA Link 01/2022 - 06/2002
28	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 07/2002
27	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2003
25	Infliximab (Remicade)FDA Link 01/2020 - 01/2004
24	Tumor Necrosis Factor InhibitorsIBA 11/2021 - 01/2003
23	AutoantibodiesIBA 01/2022 - 10/2003
23	Adalimumab (Humira)FDA Link 01/2020 - 01/2003
16	Pharmaceutical PreparationsIBA 01/2022 - 10/2003
16	golimumab FDA Link 01/2020 - 08/2009
15	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 09/2010
15	tocilizumab (atlizumab)FDA Link 11/2020 - 12/2007
14	CytokinesIBA 03/2021 - 03/2004
14	Monoclonal AntibodiesIBA 01/2019 - 11/2004
13	baricitinibIBA 01/2021 - 01/2017
13	C-Reactive ProteinIBA 01/2019 - 11/2003
12	Certolizumab Pegol FDA Link 01/2020 - 11/2008
11	ametantrone (HAQ)IBA 01/2022 - 09/2006
11	Biosimilar PharmaceuticalsIBA 01/2021 - 03/2014
11	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 02/2002
11	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2012
11	Rheumatoid FactorIBA 01/2018 - 11/2003
9	AntibodiesIBA 08/2022 - 12/2015
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
8	GlucocorticoidsIBA 11/2021 - 05/2006
8	secukinumabIBA 01/2019 - 11/2013
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 03/2002
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2014 - 08/2002
6	Peptides (Polypeptides)IBA 01/2021 - 10/2012
6	cyclic citrullinated peptideIBA 01/2021 - 09/2009
5	EpitopesIBA 01/2022 - 05/2008
5	Methylprednisolone FDA LinkGeneric 11/2021 - 11/2002
5	Interleukin-7 (Interleukin 7)IBA 03/2021 - 01/2005
5	Janus Kinase InhibitorsIBA 01/2021 - 06/2017
5	Immunoglobulin G (IgG)IBA 10/2020 - 12/2007
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2004
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 12/2006
5	amsonic acid (DAS)IBA 03/2019 - 12/2003
5	Interleukin-17 (Interleukin 17)IBA 01/2018 - 11/2013
5	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2013 - 02/2002
5	GadoliniumIBA 08/2009 - 02/2002
4	Janus KinasesIBA 01/2021 - 06/2017
4	InterferonsIBA 01/2021 - 01/2016
4	sarilumabIBA 11/2020 - 06/2017
4	EnzymesIBA 07/2020 - 06/2004
4	Immunoglobulins (Immunoglobulin)IBA 08/2015 - 12/2007
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2013 - 12/2007
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 09/2015
3	Interferon Type IIBA 12/2020 - 10/2017
3	upadacitinibIBA 01/2020 - 12/2016
3	AutoantigensIBA 11/2017 - 07/2013
3	Prednisolone (Predate)FDA LinkGeneric 12/2012 - 12/2006
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2010 - 05/2008
3	SteroidsIBA 02/2008 - 01/2004

Therapy/Procedure

100	Therapeutics 06/2022 - 02/2002
9	Biological Therapy 01/2018 - 01/2007
7	Aftercare (After-Treatment) 01/2019 - 02/2007
4	Drug Therapy (Chemotherapy) 07/2012 - 01/2004
3	Retreatment 01/2021 - 12/2011
3	Drug Tapering 01/2020 - 01/2018
3	Remission Induction 08/2013 - 01/2005
3	Injections 01/2011 - 01/2004